Optipharm.CO.LTD (153710) — Net Asset Quality Index
Optipharm.CO.LTD (153710) has a Net Asset Quality Index of 62.3% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩40.77 Billion minus total liabilities of ₩15.37 Billion yields net assets of ₩25.40 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check financial resilience of Optipharm.CO.LTD to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Optipharm.CO.LTD Net Asset Quality Index Over Time (2015–2025)
This chart shows how Optipharm.CO.LTD's Net Asset Quality Index has evolved across 11 annual periods from 2015 to 2025. As of December 2025, the index stands at 62.3%, representing net assets of ₩25.40 Billion against total assets of ₩40.77 Billion KRW. See Optipharm.CO.LTD (153710) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Optipharm.CO.LTD (2015–2025)
The table below presents the year-by-year Net Asset Quality Index for Optipharm.CO.LTD from 2015 to 2025, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Optipharm.CO.LTD stock valuation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 62.3% | ₩25.40 Billion | ₩40.77 Billion | ₩15.37 Billion | ▼ -0.8 pp |
| 2024 | 63.1% | ₩27.34 Billion | ₩43.32 Billion | ₩15.98 Billion | ▼ -0.9 pp |
| 2023 | 64.0% | ₩25.14 Billion | ₩39.28 Billion | ₩14.13 Billion | ▼ -6.4 pp |
| 2022 | 70.4% | ₩29.01 Billion | ₩41.18 Billion | ₩12.17 Billion | ▼ -4.7 pp |
| 2021 | 75.2% | ₩30.96 Billion | ₩41.17 Billion | ₩10.21 Billion | ▼ -6.6 pp |
| 2020 | 81.7% | ₩33.78 Billion | ₩41.32 Billion | ₩7.54 Billion | ▼ -3.6 pp |
| 2019 | 85.4% | ₩35.61 Billion | ₩41.72 Billion | ₩6.11 Billion | ▲ +2.2 pp |
| 2018 | 83.1% | ₩35.44 Billion | ₩42.64 Billion | ₩7.20 Billion | ▲ +18.7 pp |
| 2017 | 64.4% | ₩12.79 Billion | ₩19.84 Billion | ₩7.06 Billion | ▼ -1.2 pp |
| 2016 | 65.6% | ₩13.50 Billion | ₩20.58 Billion | ₩7.08 Billion | ▲ +40.9 pp |
| 2015 | 24.7% | ₩4.30 Billion | ₩17.41 Billion | ₩13.12 Billion | — |